title: Thymic volume is associated independently with the magnitude of short- and long-term repopulation of CD4+ T cells in HIV-infected adults after highly active antiretroviral therapy (HAART).
abstract: Age is one of the main factors involved in the rapidity and the magnitude of CD4(+) T cell repopulation in human immunodeficiency virus (HIV)-infected patients on highly active antiretroviral treatment (HAART). Improved thymic function has been suggested as the main factor associated with CD4(+) T cell restoration after HAART. This work was undertaken to determine, among host factors, the predictor variable at baseline involved in the magnitude of short- and long-term recovery of CD4(+) T cells after HAART. HIV-RNA levels and CD4(+) T cell numbers were determined in 54 HIV-infected adults at baseline and at weeks 4, 12, 48 and 96 after HAART. T cell subpopulations were determined by flow cytometry, thymic volume by computed tomography, T cell receptor excision circle (TREC)-bearing cells by quantitative polymerase chian reaction (PCR) and interleukin (IL)-7 levels by enzyme linked immunosorbent assay at baseline. The phenotype of patients' isolates was determined by infecting GHOST cells expressing CCR5 and CXCR4. The possible interference of phenotype with thymic function was also analysed. Baseline thymic volume was associated independently with the magnitude of short- and long-term recovery of CD4(+) T cells after HAART, despite the patients' viral phenotype. The measurement of thymic volume before therapy may predict the magnitude of T cell increase. This result could have important clinical implications not only in HIV-infected patients, but also in other scenarios of T cell depletion such as bone marrow transplantation and chemotherapy.
authors.affiliation: Viral Hepatitis and AIDS Study Group, Virgen del Rocio University Hospital, Seville, Spain.
authors.forename: E
authors.initials: E
authors.lastname: Ruiz-Mateos
authors.forename: A
authors.initials: A
authors.lastname: Rubio
authors.forename: A
authors.initials: A
authors.lastname: Vallejo
authors.forename: R
authors.initials: R
authors.lastname: De la Rosa
authors.forename: A
authors.initials: A
authors.lastname: Sanchez-Quijano
authors.forename: E
authors.initials: E
authors.lastname: Lissen
authors.forename: M
authors.initials: M
authors.lastname: Leal
mesh_terms: D000328:Adult; D019380:Anti-HIV Agents / Q000627:therapeutic use; D023241:Antiretroviral Therapy, Highly Active; D015496:CD4-Positive T-Lymphocytes / Q000276:immunology*; D005260:Female; D015658:HIV Infections / Q000000981:diagnostic imaging* / Q000188:drug therapy / Q000276:immunology*; D015497:HIV-1 / Q000235:genetics; D006526:Hepatitis C / Q000150:complications / Q000276:immunology; D006801:Humans; D018655:Lymphocyte Count; D008297:Male; D012367:RNA, Viral / Q000032:analysis; D013950:Thymus Gland / Q000000981:diagnostic imaging* / Q000276:immunology; D014057:Tomography, X-Ray Computed; D019562:Viral Load
chemical_list: D019380:Anti-HIV Agents; D012367:RNA, Viral